The Quantellect read.As of Nov 19, 2026, 16 active firms cover Huntington Bancshares Incorporated: 9 rate it Buy or better, 6 sit at Neutral, and 1 rate it Sell or worse, a neutral consensus. Targets are tightly clustered, $16.00 to $21.00, so the covering firms are broadly aligned. The average target of $19.00 sits 27% above the current $14.91. The rating mix has stayed broadly stable, with Buy-side ratings easing from 10 to 9 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.40 next quarter toward $1.75 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS16 active firms
Neutral
Strong Buy00%
Buy956%
Neutral638%
Sell16%
Strong Sell00%
Based on 16 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$19.00
+27.4% upside
Average target across 16 active firms as of Nov 19, 2026 vs $14.92 current
Highest Target$21.00
Average Target$19.00
Lowest Target$16.00
Detailed analyst forecasts for HBAN
Showing 1–17 of 17 named analysts shown · 16 active firms in the rating projection
As of Nov 19, 2026, 9 of 16 active firms rate HBAN a Buy (6 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
HBAN EPS & revenue forecast
EPS · NEXT QUARTER
$0.40
Range $0.37 – $0.43 · 12 analysts · +7% YoY
Next period, 12 analysts expect Huntington Bancshares Incorporated to earn $0.40 a share (range $0.37 – $0.43), versus $0.37 a year earlier. Full-year consensus is $1.53, growing to $1.75 the year after.
REVENUE · NEXT QUARTER
$2.9B
Range $2.8B – $2.9B · 12 analysts · +10% YoY
Revenue is expected to reach $2.9B (range $2.8B – $2.9B), +10.1% year-over-year. Full-year consensus is $11.1B, rising to $11.9B next year.
Top analysts covering Huntington Bancshares Incorporated
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on HBAN.
#1
Matt Olney
Stephens & Co. · Rank #196
Neutral
$18.00+20.7% to target
Overall win rate
42%
+ Follow
#2
Terry McEvoy
Stephens & Co. · Rank #286
Neutral
$18.00+20.7% to target
Overall win rate
43%
+ Follow
#3
David Long
Raymond James · Rank #315
Buy
$20.00+34.1% to target
Overall win rate
34%
+ Follow
#4
Manan Gosalia
Morgan Stanley
Neutral
$19.00+27.4% to target
Coverage
—
+ Follow
#5
John Pancari
Evercore ISI Group
Buy
$18.00+20.7% to target
Coverage
—
+ Follow
HBAN stock forecast FAQ
What is HBAN's average 12-month price target?+
The 16 active firms with a live target average $19.00 for Huntington Bancshares Incorporated over the next 12 months, ranging from a $21.00 high to a $16.00 low, as of Nov 19, 2026.
Is HBAN stock a Buy, Sell or Neutral right now?+
The current consensus is Neutral. Of the 16 active firms as of Nov 19, 2026, 9 rate it Buy or Strong Buy, 6 rate it Neutral, and 1 rate it Sell or Strong Sell.
What are the highest and lowest price targets for HBAN?+
The Street-high target is $21.00 (Wells Fargo), and the Street-low is $16.00 (Piper Sandler). The average of all 16 active-firm targets is $19.00.
How many active Wall Street firms cover HBAN?+
16 active firms have a recognized rating on Huntington Bancshares Incorporated as of Nov 19, 2026, and 16 active firms carry a live 12-month price target.
Who is the most accurate analyst covering HBAN?+
Among analysts who currently cover HBAN, Matt Olney of Stephens & Co. has the strongest overall Quantellect track record (Rank #196). Their current call is Neutral with a $18.00 target.
What is Huntington Bancshares Incorporated's projected EPS for next quarter?+
The consensus estimate is $0.40 per share (range $0.37 – $0.43) across 12 analysts. Full-year EPS is projected at $1.53, rising to $1.75 the following year.
How much revenue is Huntington Bancshares Incorporated expected to report next quarter?+
Consensus revenue is $2.9B (range $2.8B – $2.9B). Full-year revenue is projected at $11.1B, growing to $11.9B next year.
Have analysts been upgrading or downgrading HBAN lately?+
As of Nov 19, 2026, 9 of 16 active firms rate HBAN a Buy (6 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their HBAN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.